This post is also available in: Danish
Global women’s health innovation platform Femtech Insider and AI-powered research platform Proem have announced a new partnership that marks a significant step towards reducing the gap in gender-based health research and ensuring scientific discoveries in women’s health are accessible to a wider audience.
“We share the same vision as Femtech Insider – to make research more accessible and understandable. It’s not just about information; it’s about providing tools for critical thinking and innovation,” says Geet Khosla, co-founder and CEO of Proem.
Proem has developed a platform that uses the latest AI technology to summarize complex research and make it easier to understand.
The new tracker has the potential to create major changes in women’s health by:
Accelerate the understanding of research: By simplifying complex research findings, the new tracker will make it easier and faster to disseminate new knowledge.
Inspire innovation: When more people have access to up-to-date research, it opens up new ideas and approaches to women’s health technology and treatments.
Empowering patients and healthcare professionals: When both patients and doctors are better informed, they can make more informed decisions about treatment and health.
Highlight research gaps: The tracker will highlight research gaps, which can lead to new research projects and studies.
A new tool to understand and advance research
The new health tracker is based on an innovative AI model that makes it possible to summarize and explain research findings in an easily accessible way. This means that healthcare professionals, researchers and the general public can quickly stay up-to-date on the latest discoveries in women’s health.
Read also: Danish AI startup raises millions: Will revolutionize the way we share knowledge – TechSavvy
“The women’s health gap exists in part because research in the field is often inaccessible and invisible. Our partnership with Proem makes it possible to present the current research landscape, highlight gaps and inspire new innovations in women’s health,” says Kathrin Folkendt, CEO of Femtech Insider.
Women’s health research has long been neglected, resulting in misunderstandings, misdiagnoses and treatments that are not necessarily optimal for women. It wasn’t until 1993 that it became a requirement in the US to include women in clinical trials, and even in 2024, many inequalities remain. The collaboration between Femtech Insider and Proem seeks to address this inequality with the launch of a comprehensive and continuously updated Women’s Health Research Tracker.